Zurn Water Solutions Corporation
Zurn Water Solutions Corporation (RXN) Stock Competitors & Peer Comparison
See (RXN) competitors and their performances in Stock Market.
Peer Comparison Table: Regulated Water Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RXN | $64.95 | +0.90% | 11.4B | N/A | N/A | N/A |
| AWK | $145.72 | +3.91% | 28.4B | 26.25 | $5.55 | +2.14% |
| SBS | $19.51 | +1.19% | 13.3B | 7.78 | $2.51 | +3.25% |
| WTRG | $38.18 | +3.75% | 10.7B | 17.12 | $2.23 | +3.41% |
| AWR | $74.74 | +1.56% | 2.9B | 23.00 | $3.25 | +2.48% |
| CWT | $46.50 | +2.27% | 2.8B | 20.40 | $2.28 | +2.57% |
| SJW | $54.86 | -0.67% | 1.9B | 18.29 | $3.00 | +2.99% |
| HTO | $49.49 | +2.48% | 1.7B | 16.12 | $3.07 | +0.85% |
| ARIS | $19.69 | -7.43% | 1.2B | 23.73 | $0.83 | +2.45% |
| MSEX | $52.39 | +1.53% | 943.9M | 21.74 | $2.41 | +2.56% |
Stock Comparison
RXN vs AWK Comparison August 2025
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, AWK has a market cap of 28.4B. Regarding current trading prices, RXN is priced at $64.95, while AWK trades at $145.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas AWK's P/E ratio is 26.25. In terms of profitability, RXN's ROE is +0.14%, compared to AWK's ROE of +0.10%. Regarding short-term risk, RXN is less volatile compared to AWK. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check AWK's competition here
RXN vs SBS Comparison August 2025
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, SBS has a market cap of 13.3B. Regarding current trading prices, RXN is priced at $64.95, while SBS trades at $19.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas SBS's P/E ratio is 7.78. In terms of profitability, RXN's ROE is +0.14%, compared to SBS's ROE of +0.30%. Regarding short-term risk, RXN is less volatile compared to SBS. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check SBS's competition here
RXN vs WTRG Comparison August 2025
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, WTRG has a market cap of 10.7B. Regarding current trading prices, RXN is priced at $64.95, while WTRG trades at $38.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas WTRG's P/E ratio is 17.12. In terms of profitability, RXN's ROE is +0.14%, compared to WTRG's ROE of +0.10%. Regarding short-term risk, RXN is less volatile compared to WTRG. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check WTRG's competition here
RXN vs AWR Comparison August 2025
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, AWR has a market cap of 2.9B. Regarding current trading prices, RXN is priced at $64.95, while AWR trades at $74.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas AWR's P/E ratio is 23.00. In terms of profitability, RXN's ROE is +0.14%, compared to AWR's ROE of +0.14%. Regarding short-term risk, RXN is more volatile compared to AWR. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check AWR's competition here
RXN vs CWT Comparison August 2025
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, CWT has a market cap of 2.8B. Regarding current trading prices, RXN is priced at $64.95, while CWT trades at $46.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas CWT's P/E ratio is 20.40. In terms of profitability, RXN's ROE is +0.14%, compared to CWT's ROE of +0.08%. Regarding short-term risk, RXN is less volatile compared to CWT. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check CWT's competition here
RXN vs SJW Comparison August 2025
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, SJW has a market cap of 1.9B. Regarding current trading prices, RXN is priced at $64.95, while SJW trades at $54.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas SJW's P/E ratio is 18.29. In terms of profitability, RXN's ROE is +0.14%, compared to SJW's ROE of +0.07%. Regarding short-term risk, RXN is less volatile compared to SJW. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check SJW's competition here
RXN vs HTO Comparison August 2025
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, HTO has a market cap of 1.7B. Regarding current trading prices, RXN is priced at $64.95, while HTO trades at $49.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas HTO's P/E ratio is 16.12. In terms of profitability, RXN's ROE is +0.14%, compared to HTO's ROE of +0.07%. Regarding short-term risk, RXN is less volatile compared to HTO. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check HTO's competition here
RXN vs ARIS Comparison August 2025
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, ARIS has a market cap of 1.2B. Regarding current trading prices, RXN is priced at $64.95, while ARIS trades at $19.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas ARIS's P/E ratio is 23.73. In terms of profitability, RXN's ROE is +0.14%, compared to ARIS's ROE of +0.08%. Regarding short-term risk, RXN is less volatile compared to ARIS. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check ARIS's competition here
RXN vs MSEX Comparison August 2025
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, MSEX has a market cap of 943.9M. Regarding current trading prices, RXN is priced at $64.95, while MSEX trades at $52.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas MSEX's P/E ratio is 21.74. In terms of profitability, RXN's ROE is +0.14%, compared to MSEX's ROE of +0.10%. Regarding short-term risk, RXN is less volatile compared to MSEX. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check MSEX's competition here
RXN vs CWCO Comparison August 2025
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, CWCO has a market cap of 452.5M. Regarding current trading prices, RXN is priced at $64.95, while CWCO trades at $28.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas CWCO's P/E ratio is 28.43. In terms of profitability, RXN's ROE is +0.14%, compared to CWCO's ROE of +0.00%. Regarding short-term risk, RXN is less volatile compared to CWCO. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check CWCO's competition here
RXN vs YORW Comparison August 2025
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, YORW has a market cap of 438.5M. Regarding current trading prices, RXN is priced at $64.95, while YORW trades at $30.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas YORW's P/E ratio is 22.23. In terms of profitability, RXN's ROE is +0.14%, compared to YORW's ROE of +0.09%. Regarding short-term risk, RXN is less volatile compared to YORW. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check YORW's competition here
RXN vs ARTNA Comparison August 2025
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, ARTNA has a market cap of 339.2M. Regarding current trading prices, RXN is priced at $64.95, while ARTNA trades at $32.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas ARTNA's P/E ratio is 15.78. In terms of profitability, RXN's ROE is +0.14%, compared to ARTNA's ROE of +0.09%. Regarding short-term risk, RXN is more volatile compared to ARTNA. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check ARTNA's competition here
RXN vs VWTR Comparison August 2025
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, VWTR has a market cap of 288.2M. Regarding current trading prices, RXN is priced at $64.95, while VWTR trades at $15.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas VWTR's P/E ratio is 9.29. In terms of profitability, RXN's ROE is +0.14%, compared to VWTR's ROE of +0.17%. Regarding short-term risk, RXN is more volatile compared to VWTR. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check VWTR's competition here
RXN vs GWRS Comparison August 2025
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, GWRS has a market cap of 264.1M. Regarding current trading prices, RXN is priced at $64.95, while GWRS trades at $9.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas GWRS's P/E ratio is 41.83. In terms of profitability, RXN's ROE is +0.14%, compared to GWRS's ROE of +0.10%. Regarding short-term risk, RXN is less volatile compared to GWRS. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check GWRS's competition here
RXN vs CDZIP Comparison August 2025
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, CDZIP has a market cap of 263.5M. Regarding current trading prices, RXN is priced at $64.95, while CDZIP trades at $17.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas CDZIP's P/E ratio is -20.98. In terms of profitability, RXN's ROE is +0.14%, compared to CDZIP's ROE of -1.07%. Regarding short-term risk, RXN is more volatile compared to CDZIP. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check CDZIP's competition here
RXN vs CDZI Comparison August 2025
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, CDZI has a market cap of 246.4M. Regarding current trading prices, RXN is priced at $64.95, while CDZI trades at $3.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas CDZI's P/E ratio is -5.47. In terms of profitability, RXN's ROE is +0.14%, compared to CDZI's ROE of -1.07%. Regarding short-term risk, RXN is less volatile compared to CDZI. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check CDZI's competition here
RXN vs PCYO Comparison August 2025
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, PCYO has a market cap of 234.7M. Regarding current trading prices, RXN is priced at $64.95, while PCYO trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas PCYO's P/E ratio is 17.41. In terms of profitability, RXN's ROE is +0.14%, compared to PCYO's ROE of +0.11%. Regarding short-term risk, RXN is less volatile compared to PCYO. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check PCYO's competition here